Evaluation of drugs acting at glutamate transporters in organotypic hippocampal cultures: New evidence on substrates and blockers in excitotoxicity

Neurochemical Research

Volumn 27, Issue 1-2, 2002, Pages 5-13

  O’Shea, Ross D ^a   Fodera, Melissa V ^a   Apricó, Karina ^a   Dehnes, Yvette ^b   Danbolt, Niels C ^b   Crawford, Duncan ^c   Beart, Philip M ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF OSLO   (Norway)

^c Langford House   (United Kingdom)

Author keywords

Excitotoxicity; Glutamate transporter; Heteroexchange; L Glutamate; Neuroprotection; Organotypic hippocampal culture

Indexed keywords

2 (CARBOXYCYCLOPROPYL)GLYCINE; 2,4 PYRROLIDINEDICARBOXYLIC ACID; 3 METHYLGLUTAMIC ACID; 4 METHYLGLUTAMIC ACID; AMINO ACID DERIVATIVE; BETA BENZYLOXYASPARTATE; CARBOXYLIC ACID DERIVATIVE; DIHYDROKAINIC ACID; EXCITATORY AMINO ACID; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; LACTATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE; TISSUE CULTURE;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; CELL SURVIVAL; DRUG EVALUATION; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR SPACE; GLUTAMIC ACID; HIPPOCAMPUS; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA;

EID: 0036129209     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014813518604     Document Type: Article

References (55)

1. Glutamate: A neurotransmitter in mammalian brain
2. Excitatory amino acids as a final common pathway for neurologic disorders
3. Cloned glutamate receptors
4. Glutamate uptake
5. Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture
6. High affinity glutamate transporters: Regulation of expression and activity
7. Deficient glutamate transport is associated with neurodegeneration in Alzheimer’s disease
8. Heterogeneity and functional properties of subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system
9. Astrocytes: Glutamate producers for neurons
10. Strategies for studies of neurotoxic mechanisms involving deficient transport of L-glutamate: Antisense knockout in rat brain in vivo and changes in the neurotransmitter metabolism following inhibition of glutamate transport in guinea pig brain slices
11. Glutamate transporter protein subtypes are expressed differentially during rat CNS development
12. Developmental expression of excitatory amino acid transporter 5: A photoreceptor and bipolar cell glutamate transporter in rat retina
13. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
14. Excitatory amino acid transporters as emerging targets for central nervous system therapeutics
15. A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system
16. Markers for neuronal degeneration in organotypic slice cultures
17. Differential expression of two glial glutamate transporters in the rat brain: Quantitative and immunocytochemical observations
18. Localization of transporters using transporter-specific antibodies
19. Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2
20. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay
21. The log transformation is special
22. A simple method for organotypic cultures of nervous tissue
23. Long-term hippocampal slices: A model system for investigating synaptic mechanisms and pathologic processes
24. Glia modulate the response of murine cortical neurons to excitotoxicity: Glia exacerbate AMPA neurotoxicity
25. Neurotoxicity of acute glutamate transport blockade depends on coactivation of both NMDA and AMPA/Kainate receptors in organotypic hippocampal cultures
26. Glutamate toxicity in neuron-enriched and neuron-astrocyte co-cultures: Effect of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylate
27. Acute neurotoxicity of L-glutamate induced by impairment of the glutamate uptake system
28. The competitive transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate triggers excitotoxicity in rat cortical neuron-astrocyte co-cultures via glutamate release rather than uptake inhibition
29. Cytotoxic effects of kainate ligands on HEK cell lines expressing recombinant kainate receptors
30. The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors
31. Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures
32. 2+ increase
33. Development of kainic acid and N-methyl-D-aspartic acid toxicity in organotypic hippocampal cultures
34. Excitatory and inhibitory pathways modulate kainate excitotoxicity in hippocampal slice cultures
35. Kainate-induced apoptosis in cultured murine cerebellar granule cells elevates expression of the cell cycle gene cyclin D1
36. 2+ uptake are selectively vulnerable to AMPA/kainate receptor-mediated toxicity
37. Local injection of kainic acid causes widespread degeneration of NADPH-d neurons and induction of NADPH-d in neurons, endothelial cells and reactive astrocytes
38. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity
39. Molecular pharmacology and physiology of glutamate transporters in the central nervous system
40. Inhibition of glutamate uptake with L-trans-pyrrolidine-2,4-dicarboxylate potentiates glutamate toxicity in primary hippocampal cultures
41. The glutamate transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures
42. 3H]-(2S,4R)-4-methylglutamate: A novel ligand for the characterisation of glutamate transporters
43. Molecular pharmacology of 4-substituted glutamic acid analogues at ionotropic and metabotropic excitatory amino acid receptors
44. 3H](2S,4R)-4-methylglutamate
45. 3H]-(2S,4R)-4-methylglutamate: Pharmacological characterization in rabbit brain membranes
46. Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes
47. Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST
48. The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms
49. DL-threo-β-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters
50. Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin
51. 3H]-glutamate transport activity: Pharmacologic specificity and regulation by sodium and potassium
52. Spontaneous pyramidal cell death in organotypic slice cultures from rat hippocampus is prevented by glutamate receptor antagonists
53. Evidence that reversed glutamate uptake contributes significantly to glutamate release following experimental injury to the rat spinal cord
54. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: Studies with DL-threo-β-benzyloxyaspartate
55. Glutamate release in severe brain ischaemia is mainly by reversed uptake